Surgalign Holdings, Inc. (SRGA)
Dopo ore:
| Chiusura precedente | 3,4700 |
| Aperto | 3,5000 |
| Denaro | 3,4600 x 1400 |
| Lettera | 3,6900 x 900 |
| Min-Max giorno | 3,5000 - 3,6900 |
| Intervallo di 52 settimane | 3,3000 - 48,6000 |
| Volume | |
| Media Volume | 88.019 |
| Capitalizzazione | 23,317M |
| Beta (5 anni mensile) | 2,23 |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | -14,8540 |
| Prossima data utili | 04 ago 2022 - 08 ago 2022 |
| Rendimento e dividendo (forward) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | 40,00 |
- GlobeNewswire
Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
DEERFIELD, Ill., June 03, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (NASDAQ: SRGA), a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced that it has granted restricted stock unit awards to five (5) employees, none of whom was an executive officer, as an inducement for them to accept employment with Surgalign, and representing the right to receive, in the aggregate, up to 27,877 shares of Surgalign common
- GlobeNewswire
Surgalign Holdings, Inc. Announces 1-for-30 Reverse Stock Split
DEERFIELD, Ill., May 16, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced that at its Annual Meeting of Stockholders (“Annual Meeting”) on May 10, 2022, the Board and stockholders of the Company approved a reverse stock split of the Company’s issued and outstanding shares of its common stock and authorized the Board to select the ratio of the
- GlobeNewswire
Surgalign Holdings, Inc. Announces First Quarter 2022 Results and Raises Full Year 2022 Revenue Guidance Range
DEERFIELD, Ill., May 10, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, today announced financial results for its 2022 first quarter ended March 31, 2022. Financial Highlights and Key Events: Received FDA 510(k) clearance for HOLO Portal™ System, the world's first AI-driven AR guidance system for spine surgery;1st Holo Portal™ site up and running;1st succe
